Skip to content
Screener

Core Laboratories CLB Operating Segment Production Enhancement — Operating Income

Other segment segments

Operating Segment Reservoir Description
$1.15M-51.0%
Corporate And Other
-$63K-111%

Similar metrics at other companies

Helix Energy Solutions Group logo
HLXProduction Facilities — Operating Income
$15.81M+257%
Gray Television logo
GTNProduction Companies — Operating Income
-$2M+66.7%
Antero Resources logo
ARExploration And Production — Operating Income
$391.45M+75.4%
M/I Homes logo
MHOOperating Segments — Operating Income
$105.54M-34.0%
Enviri logo
NVRIOperating Segments — Operating Income
-$244.42M-674%
Deere & Company logo
DEProduction And Precision Agriculture — Operating Income
$706M-38.5%

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$520.79M+22.8%
Enterprise value$665.81M+16.8%
P/E17.9×+3.6×
P/S1×+0.2×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 6:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-198109
Three months ended March 31, 2026Reservoir DescriptionProduction EnhancementCorporate &Other (1)Consolidated
Depreciation and amortization2,779985—3,764
Other operating (income) expense, net (3)(431)(131)(463)(1,025)
Foreign exchange (gain) loss, net (3)478(140)42380
CODM Measure - Segment operating income1,146804(63)1,887
Supplemental Disclosures:
Total assets333,341141,142113,245587,728
Capital expenditures4,509306764,891
Three months ended March 31, 2025

Item 1. Financial Statements

FAQ

What is Core Laboratories's operating segment production enhancement — operating income?
Core Laboratories (CLB) reported operating segment production enhancement — operating income of $804K in Q1 2026.
How has Core Laboratories's operating segment production enhancement — operating income changed year-over-year?
Core Laboratories's operating segment production enhancement — operating income decreased by 46.5% year-over-year, from $1.5M to $804K.
What is the long-term trend for Core Laboratories's operating segment production enhancement — operating income?
Over 3 years (2021 to 2025), Core Laboratories's operating segment production enhancement — operating income has grown at a -7.4% compound annual growth rate (CAGR), from $15.16M to $12.06M.
What does operating segment production enhancement — operating income mean?
This metric represents the profit or loss generated by the production enhancement segment after deducting all operating expenses from its revenue. It is a key indicator of the segment's operational efficiency and core business profitability.

Ask your AI about Core Laboratories's operating segment production enhancement — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude